CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-18 | Bowden Christopher Chief Medical Officer | Option exercise | +46,608 | $50.40 | $2.3M | 63,980 |
| 2021-06-18 | Bowden Christopher Chief Medical Officer | Sale | −48,493 | $60.11 | $2.9M | 15,487 |
| 2021-06-18 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −1,885 | 0 | ||
| 2021-06-18 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −46,608 | 992 | ||
| 2021-06-17 | Bowden Christopher Chief Medical Officer | Option exercise | +2,502 | $39.76 | $99K | 17,989 |
| 2021-06-17 | Bowden Christopher Chief Medical Officer | Sale | −2,502 | $60.02 | $150K | 15,487 |
| 2021-06-17 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −2,502 | 1,885 | ||
| 2021-06-10 | Bowden Christopher Chief Medical Officer | Option exercise | +20,853 | $39.76 | $829K | 36,340 |
| 2021-06-10 | Bowden Christopher Chief Medical Officer | Sale | −20,853 | $60.06 | $1.3M | 15,487 |
| 2021-06-10 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −20,853 | 4,387 | ||
| 2021-06-09 | Bowden Christopher Chief Medical Officer | Option exercise | +7,149 | $39.76 | $284K | 22,636 |
| 2021-06-09 | Bowden Christopher Chief Medical Officer | Sale | −7,149 | $60.16 | $430K | 15,487 |
| 2021-06-09 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −7,149 | 25,240 | ||
| 2021-06-08 | Bowden Christopher Chief Medical Officer | Option exercise | +6,675 | $39.76 | $265K | 22,162 |
| 2021-06-08 | Bowden Christopher Chief Medical Officer | Sale | −6,675 | $60.07 | $401K | 15,487 |
| 2021-06-08 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −6,675 | 32,389 | ||
| 2021-06-07 | Bowden Christopher Chief Medical Officer | Option exercise | +4,268 | $39.76 | $170K | 19,755 |
| 2021-06-07 | Bowden Christopher Chief Medical Officer | Sale | −4,268 | $60.04 | $256K | 15,487 |
| 2021-06-07 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −4,268 | 39,064 | ||
| 2021-05-28 | CLARK IAN T Director | Option exercise | +1,686 | 4,964 |
Page 40 of 48 · 941 trades